First, it’s essential to understand that the primary purpose of the COVID-19 Plandemic<\/em> was to impose a mandatory Covid vaccination regime on the entire world community of nations.<\/h3>\nThe Khazarian perpetrators of this Covid injection genocide also planned for an entire decade of COVID-19 ‘vaccines’ and boosters.\u00a0 They really wanted every person on the planet getting their 3 or 4 yearly jabs until they had been sufficiently poisoned and programmed.<\/h3>\nHowever, the Global Covid ‘Vaccine’ Truth Movement unexpectedly emerged fast and furiously out of nowhere.\u00a0 In so doing, the vax truthers threw a ginormous wrench into the Covid jab juggernaut bringing it to a screeching halt.<\/h3>\n
Graph of daily COVID-19 \u2018vaccine\u2019 doses administered to date reveals
\nthe inevitable termination of the Covid Super Vaccination Agenda<\/em><\/a><\/strong><\/p>\nThe CV19 vaccination hard data now indicates that the whole Covid jab depopulation scheme has been thwarted to a great degree.\u00a0 And, that most nations have considerably slowed their respective weaponized Covid shot genocides.<\/h3>\nOf course, it remains to be seen just how much of an uptick in Covid ‘vaccine’-induced deaths and injuries occurs after the same perps flip the switch on the advanced build-out of the 5G power grids in the urban kill zones around the globe. See: 5G Super-Hotspots: You better know where the \u201ckill zones\u201d are located!<\/a><\/h3>\nState of the Nation<\/a>
\nMay 8, 2023<\/h3>\nN.B. When Big Pharma<\/em> vaccine production data aligns with official Covid vaccination\u00a0 data as presented below, you know this Plandemic<\/em> has not gone according to their nefarious NWO plans.<\/h3>\n
\nNew COVID Vaccinations\/Boosters Slow To A Trickle<\/strong><\/h1>\nZeroHedge.com<\/p>\n
Pharma company\u00a0Pfizer<\/a>, makers of popular\u00a0Covid-19 vaccine<\/a>\u00a0Comirnaty, reported their Q1 financials yesterday.<\/p>\nWhile the company exceeded expectations,\u00a0there is nevertheless a big chunk of revenue missing<\/strong>\u00a0in this quarter\u2019s report compared to the same time last year. Total revenue was down 29 percent since Q1 of 2022.<\/p>\nAs Statista’s Katharina Buchholz notes,<\/a>\u00a0this change is closely related to the number of Covid-19 vaccines given out globally<\/strong>.\u00a0Numbers from Our World in Data<\/a>\u00a0show that\u00a0new vaccinations around the world have slowed to a trickle.<\/strong><\/p>\nWhile in mid-2021, an average of as many as 38 million doses were given out each day, this had decreased to between 500,000 to one million daily doses most recently.<\/p>\n
![\"Infographic:](\"https:\/\/cdn.statcdn.com\/Infographic\/images\/normal\/29906.jpeg\")
<\/a><\/p>\nYou will find more infographics at\u00a0Statista<\/a><\/em><\/p>\nInterestingly, booster shots have generally not overtaken initial protocol immunizations, instead staying far behind them in 2023 after having been the most common type of Covid-19 vaccination for a short while in mid-2022.\u00a0<\/strong>Booster doses of Covid-19 vaccines have been available in many developed countries \u2013 which is where most coronavirus vaccines were given out in general – and have continued to be recommended at least for older people. However, uptake has been far from universal.\u00a0For example, while close to 70 percent of the U.S. population had received a full initial immunization<\/a>\u00a0against Covid-19 most recently, only around 17 percent had received a booster. The numbers were 94 percent and 43 percent for those over the age of 65, respectively.<\/p>\nThe number of Covid-19 booster shots might increase once more if an annual vaccination against the disease would be recommended.\u00a0In the United States,\u00a0the FDA in January voted in favor of such a regimen<\/a>\u00a0that would work similar to the annual flu shot and could potentially start to be given out this fall.\u00a0<\/strong>More than one annual shot could still be recommended for older or immuno-compromised people.<\/p>\n
However, the Global Covid ‘Vaccine’ Truth Movement unexpectedly emerged fast and furiously out of nowhere.\u00a0 In so doing, the vax truthers threw a ginormous wrench into the Covid jab juggernaut bringing it to a screeching halt.<\/h3>\n
\nthe inevitable termination of the Covid Super Vaccination Agenda<\/em><\/a><\/strong><\/p>\n
The CV19 vaccination hard data now indicates that the whole Covid jab depopulation scheme has been thwarted to a great degree.\u00a0 And, that most nations have considerably slowed their respective weaponized Covid shot genocides.<\/h3>\nOf course, it remains to be seen just how much of an uptick in Covid ‘vaccine’-induced deaths and injuries occurs after the same perps flip the switch on the advanced build-out of the 5G power grids in the urban kill zones around the globe. See: 5G Super-Hotspots: You better know where the \u201ckill zones\u201d are located!<\/a><\/h3>\nState of the Nation<\/a>
\nMay 8, 2023<\/h3>\nN.B. When Big Pharma<\/em> vaccine production data aligns with official Covid vaccination\u00a0 data as presented below, you know this Plandemic<\/em> has not gone according to their nefarious NWO plans.<\/h3>\n
\nNew COVID Vaccinations\/Boosters Slow To A Trickle<\/strong><\/h1>\nZeroHedge.com<\/p>\n
Pharma company\u00a0Pfizer<\/a>, makers of popular\u00a0Covid-19 vaccine<\/a>\u00a0Comirnaty, reported their Q1 financials yesterday.<\/p>\nWhile the company exceeded expectations,\u00a0there is nevertheless a big chunk of revenue missing<\/strong>\u00a0in this quarter\u2019s report compared to the same time last year. Total revenue was down 29 percent since Q1 of 2022.<\/p>\nAs Statista’s Katharina Buchholz notes,<\/a>\u00a0this change is closely related to the number of Covid-19 vaccines given out globally<\/strong>.\u00a0Numbers from Our World in Data<\/a>\u00a0show that\u00a0new vaccinations around the world have slowed to a trickle.<\/strong><\/p>\nWhile in mid-2021, an average of as many as 38 million doses were given out each day, this had decreased to between 500,000 to one million daily doses most recently.<\/p>\n
<\/a><\/p>\nYou will find more infographics at\u00a0Statista<\/a><\/em><\/p>\nInterestingly, booster shots have generally not overtaken initial protocol immunizations, instead staying far behind them in 2023 after having been the most common type of Covid-19 vaccination for a short while in mid-2022.\u00a0<\/strong>Booster doses of Covid-19 vaccines have been available in many developed countries \u2013 which is where most coronavirus vaccines were given out in general – and have continued to be recommended at least for older people. However, uptake has been far from universal.\u00a0For example, while close to 70 percent of the U.S. population had received a full initial immunization<\/a>\u00a0against Covid-19 most recently, only around 17 percent had received a booster. The numbers were 94 percent and 43 percent for those over the age of 65, respectively.<\/p>\nThe number of Covid-19 booster shots might increase once more if an annual vaccination against the disease would be recommended.\u00a0In the United States,\u00a0the FDA in January voted in favor of such a regimen<\/a>\u00a0that would work similar to the annual flu shot and could potentially start to be given out this fall.\u00a0<\/strong>More than one annual shot could still be recommended for older or immuno-compromised people.<\/p>\n
State of the Nation<\/a>
\nMay 8, 2023<\/h3>\nN.B. When Big Pharma<\/em> vaccine production data aligns with official Covid vaccination\u00a0 data as presented below, you know this Plandemic<\/em> has not gone according to their nefarious NWO plans.<\/h3>\n
\nNew COVID Vaccinations\/Boosters Slow To A Trickle<\/strong><\/h1>\nZeroHedge.com<\/p>\n
Pharma company\u00a0Pfizer<\/a>, makers of popular\u00a0Covid-19 vaccine<\/a>\u00a0Comirnaty, reported their Q1 financials yesterday.<\/p>\nWhile the company exceeded expectations,\u00a0there is nevertheless a big chunk of revenue missing<\/strong>\u00a0in this quarter\u2019s report compared to the same time last year. Total revenue was down 29 percent since Q1 of 2022.<\/p>\nAs Statista’s Katharina Buchholz notes,<\/a>\u00a0this change is closely related to the number of Covid-19 vaccines given out globally<\/strong>.\u00a0Numbers from Our World in Data<\/a>\u00a0show that\u00a0new vaccinations around the world have slowed to a trickle.<\/strong><\/p>\nWhile in mid-2021, an average of as many as 38 million doses were given out each day, this had decreased to between 500,000 to one million daily doses most recently.<\/p>\n
<\/a><\/p>\nYou will find more infographics at\u00a0Statista<\/a><\/em><\/p>\nInterestingly, booster shots have generally not overtaken initial protocol immunizations, instead staying far behind them in 2023 after having been the most common type of Covid-19 vaccination for a short while in mid-2022.\u00a0<\/strong>Booster doses of Covid-19 vaccines have been available in many developed countries \u2013 which is where most coronavirus vaccines were given out in general – and have continued to be recommended at least for older people. However, uptake has been far from universal.\u00a0For example, while close to 70 percent of the U.S. population had received a full initial immunization<\/a>\u00a0against Covid-19 most recently, only around 17 percent had received a booster. The numbers were 94 percent and 43 percent for those over the age of 65, respectively.<\/p>\nThe number of Covid-19 booster shots might increase once more if an annual vaccination against the disease would be recommended.\u00a0In the United States,\u00a0the FDA in January voted in favor of such a regimen<\/a>\u00a0that would work similar to the annual flu shot and could potentially start to be given out this fall.\u00a0<\/strong>More than one annual shot could still be recommended for older or immuno-compromised people.<\/p>\n
\n
New COVID Vaccinations\/Boosters Slow To A Trickle<\/strong><\/h1>\nZeroHedge.com<\/p>\n
Pharma company\u00a0Pfizer<\/a>, makers of popular\u00a0Covid-19 vaccine<\/a>\u00a0Comirnaty, reported their Q1 financials yesterday.<\/p>\nWhile the company exceeded expectations,\u00a0there is nevertheless a big chunk of revenue missing<\/strong>\u00a0in this quarter\u2019s report compared to the same time last year. Total revenue was down 29 percent since Q1 of 2022.<\/p>\nAs Statista’s Katharina Buchholz notes,<\/a>\u00a0this change is closely related to the number of Covid-19 vaccines given out globally<\/strong>.\u00a0Numbers from Our World in Data<\/a>\u00a0show that\u00a0new vaccinations around the world have slowed to a trickle.<\/strong><\/p>\nWhile in mid-2021, an average of as many as 38 million doses were given out each day, this had decreased to between 500,000 to one million daily doses most recently.<\/p>\n
<\/a><\/p>\nYou will find more infographics at\u00a0Statista<\/a><\/em><\/p>\nInterestingly, booster shots have generally not overtaken initial protocol immunizations, instead staying far behind them in 2023 after having been the most common type of Covid-19 vaccination for a short while in mid-2022.\u00a0<\/strong>Booster doses of Covid-19 vaccines have been available in many developed countries \u2013 which is where most coronavirus vaccines were given out in general – and have continued to be recommended at least for older people. However, uptake has been far from universal.\u00a0For example, while close to 70 percent of the U.S. population had received a full initial immunization<\/a>\u00a0against Covid-19 most recently, only around 17 percent had received a booster. The numbers were 94 percent and 43 percent for those over the age of 65, respectively.<\/p>\nThe number of Covid-19 booster shots might increase once more if an annual vaccination against the disease would be recommended.\u00a0In the United States,\u00a0the FDA in January voted in favor of such a regimen<\/a>\u00a0that would work similar to the annual flu shot and could potentially start to be given out this fall.\u00a0<\/strong>More than one annual shot could still be recommended for older or immuno-compromised people.<\/p>\n
While the company exceeded expectations,\u00a0there is nevertheless a big chunk of revenue missing<\/strong>\u00a0in this quarter\u2019s report compared to the same time last year. Total revenue was down 29 percent since Q1 of 2022.<\/p>\n As Statista’s Katharina Buchholz notes,<\/a>\u00a0this change is closely related to the number of Covid-19 vaccines given out globally<\/strong>.\u00a0Numbers from Our World in Data<\/a>\u00a0show that\u00a0new vaccinations around the world have slowed to a trickle.<\/strong><\/p>\n While in mid-2021, an average of as many as 38 million doses were given out each day, this had decreased to between 500,000 to one million daily doses most recently.<\/p>\n You will find more infographics at\u00a0Statista<\/a><\/em><\/p>\n Interestingly, booster shots have generally not overtaken initial protocol immunizations, instead staying far behind them in 2023 after having been the most common type of Covid-19 vaccination for a short while in mid-2022.\u00a0<\/strong>Booster doses of Covid-19 vaccines have been available in many developed countries \u2013 which is where most coronavirus vaccines were given out in general – and have continued to be recommended at least for older people. However, uptake has been far from universal.\u00a0For example, while close to 70 percent of the U.S. population had received a full initial immunization<\/a>\u00a0against Covid-19 most recently, only around 17 percent had received a booster. The numbers were 94 percent and 43 percent for those over the age of 65, respectively.<\/p>\n The number of Covid-19 booster shots might increase once more if an annual vaccination against the disease would be recommended.\u00a0In the United States,\u00a0the FDA in January voted in favor of such a regimen<\/a>\u00a0that would work similar to the annual flu shot and could potentially start to be given out this fall.\u00a0<\/strong>More than one annual shot could still be recommended for older or immuno-compromised people.<\/p>\n<\/a><\/p>\n